Ipca Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 17, 2011, inter alia, have approved amalgamation of Tonira Pharma Limited with the Company with effect from April 01, 2011 (being the appointed date) through a Scheme of Amalgamation. The Scheme envisages an exchange ratio of 6 (Six) equity shares of Rs. 2/- each fully paid-up of Ipca Laboratories Limited for every 100 (One Hundred) equity shares of Rs. 10/- each fully paid-up of Tonira Pharma Limited. The exchange ratio is based on the joint valuation made by M/s. Natvarlal Vepari & Co., Chartered Accountants and M/s. G. M. Kapadia & Co., Chartered Accountants. The proposed scheme of Amalgamation will be subject to all necessary permissions and approvals, as may be required. Tonira Pharma Ltd has informed BSE that pursuant to the Direction of the Hon'able High Court of Gujarat at Ahmedahad, the meetings of the Unsecured Creditors and the Equity Shareholders of the Company, were held on December 30, 2011, at its Registered Office of at Plot No. 23-24, GIDC Estate, Nandesari, Vadodara - 391340. In the said Meetings, the Equity Shareholders and Unsecured Creditors have passed the resolutions approving the Merger of the Company with Ipca Laboratories Ltd. (As Per BSE Announcement Dated on 30.12.2011) Ipca Laboratories Ltd has informed BSE that pursuant to the Direction of the Hon'able High Court of Judicature at Bombay, the meetings of the Equity Shareholders and the Unsecured Creditors of the Company were held on January 20, 2012. In the said Meetings, the Equity Shareholders and Unsecured Creditors have passed the resolutions approving the merger of Tonira Pharma Ltd with the Company. (As Per BSE Announcement Dated on 20.01.2012) Ipca Laboratories Ltd has informed BSE that pursuant to an order dated March 30, 2012 passed by the Hon'able High Court of Judicature at Bombay and order dated April 02, 2012 passed by the Hon'able High Court of Gujarat at Ahmedabad, Tonira Pharma Ltd, a Company listed on the Bombay Stock Exchange Ltd. has merged with this Company. As requited, the orders passed by the Hon'able High Courts have been filed with the Registrar of Companies, Gujarat on May 15, 2012 and Registrar of Companies, Maharashtra on May 16, 2012. At the meeting of the Board of Directors of the Company held on May 16, 2012 has fixed May 31, 2012 as the record date for Tonira Pharma Limited members entitlement of the shares in the ratio of 6 (Six) fully paid up equity shares of Rs 2/- each of the Company for every 100 (One Hundred) fully paid up equity shares of Rs 10/- each held by them in Tonira Pharma Ltd. being the share exchange ratio fixed for merger. However, as per the Scheme of Amalgamation, no shares of Ipca Laboratories Ltd. to be issued or allotted in respect of Ipca Laboratories Ltd.'s shareholding in Tonira Pharma Ltd. Tonira Pharma Ltd has informed BSE that pursuant to an order dt. March 30, 2012 passed by the Hon'able High Court of Judicature at Bombay and order dt. April 02, 2012 passed by Hon'able Gujarat High Court, this Company (Tonira Pharma Ltd.) has merged with Ipca Laboratories Ltd, a Company listed on Bombay Stock Exchange Ltd and National Stock Exchange Ltd. As required, the order passed by the Hon'able High Courts has been filed with the Registrar of Companies, Mumbai (ROC) on May 16, 2012 and Registrar of Companies Gujarat on May 15, 2012 under Form 21 and the said orders are effective upon filing of the said Form 21 with the concerned ROC. At the meeting of the Board of Directors of Ipca Laboratories Ltd. held on May 16, 2012, the said Company has fixed May 31, 2012 as the record date for this Company members entitlement of the shares of Ipca Laboratories Ltd. in the ratio of 6 (Six) Equity Shares of Rs. 2/- each fully paid up of Ipca Laboratories Ltd. for every 100 (One Hundred) Equity Shares of Rs. 10/- each held by the members in this Company, being the exchange ratio fixed for merger. However, as per the scheme of amalgamation no shares of Ipca Laboratories Ltd to be issued or allotted in respect of Ipca Laboratories Ltd's shareholding in Tonira Pharma Ltd. (As Per BSE Announcement Website Dated on 17/05/2012) SUB. : - Scheme of Amalgamation of Tonira Pharma Ltd. (Scrip Code 530155) Trading members of the Exchange are hereby informed that, Tonira Pharma Ltd. has fixed a Record Date to determine the entitlement of shareholders of Tonira Pharma Ltd., pursuant to the Scheme of Amalgamation of Tonira Pharma Ltd. with IPCA Laboratories Ltd approved by Hon'ble High Court of Gujarat and Hon'ble High Court of Judicature at Bombay. Trading Members are advised not to deal in the equity shares of Tonira Pharma Ltd. with effect from the under mentioned date. COMPANY NAME CODE Tonira Pharma Ltd. (530155) RECORD DATE 31/05/2012 PURPOSE Scheme of Amalgamation: - Amalgamation of Tonira Pharma Ltd. with IPCA Laboratories Ltd. Upon the Scheme becoming effective, in consideration for the amalgamation, IPCA Laboratories Ltd., shall issue and allot 6 (SIX) equity shares of Rs. 2/- (RUPEES TWO) each fully paid for every 100 (ONE HUNDRED) equity shares of Rs. 10/- (RUPEES TEN) each held in Tonira Pharma Ltd. NO DEALINGS FROM 30/05/2012 DR-043/2012-2013 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 21.05.2012) Ipca Laboratories Ltd has announced the following results for the quarter ended December 31, 2012: The Unaudited results for the Quarter ended December 31, 2012 The Company has posted a net profit of Rs. 878.90 million for the quarter ended December 31, 2012 where as the same was at Rs. 639.30 million for the quarter ended December 31, 2011. Total Income is Rs. 7049.90 million for the quarter ended December 31, 2012 where as the same was at Rs. 6188.60 million for the quarter ended December 31, 2011. 'Pursuant to the scheme of amalgamation of Tonira Pharma Limited (Tonira) with the Company w.e.f. appointed date April 01,2011, the results of operations for the quarter and nine months ended December,2012 includes the operations of the business of Tonira. Since this effect of amalgamation was given in the quarter ended March,2012, the figures of the comparative quarter and nine months ended December,2011 does not include the result of operations of Tonira and hence not comparable.' (As per BSE Announcement Dated on 30.01.2013)